[1] |
KIM H, HIRANO H, EDAHIRO A, et al. Sarcopenia: prevalence and associated factors based on different suggested definitions in community-dwelling older adults[J]. Geriatr Gerontol Int, 2016, 16(1): 110-122.
|
[2] |
World Health Organization. Chronic obstructive pulmonary disease (COPD)[EB/OL]. (2024-11-06) [2025-01-23]. https://www.who.int/news-room/fact-sheets/detail/chronic-obstructive-pulmonary-disease-(copd).
|
[3] |
JUBY A G, DAVIS C M J, MINIMAANA S, et al. Observational cohort study of highly functioning community-dwelling older adults to assess their sarcopenic status, leisure physical activity, and quality of life over 12-months[J]. Heliyon, 2023, 9(9): e20078.
|
[4] |
CHEN L K, WOO J, ASSANTACHAI P, et al. Asian Working Group for Sarcopenia: 2019 consensus update on sarcopenia diagnosis and treatment[J]. J Am Med Dir Assoc, 2020, 21(3): 300-7.e2.
|
[5] |
LI Z, ZHUANG J, ZHANG S, et al. Therapeutic effects of traditional Chinese exercises on musculoskeletal pain: a systematic review and meta-analysis[J]. Pain Res Manag, 2021, 2021: 5584997.
|
[6] |
HARRISON J E, WEBER S, JAKOB R, et al. ICD-11: an international classification of diseases for the twenty-first century[J]. BMC Med Inform Decis Mak, 2021, 21(Suppl 6): 206.
|
[7] |
REDDY B, FAN A Y. Incorporation of complementary and traditional medicine in ICD-11[J]. BMC Med Inform Decis Mak, 2022, 21(Suppl 6): 381.
|
[8] |
LAM W C, LYU A, BIAN Z. ICD-11: impact on traditional Chinese medicine and world healthcare systems[J]. Pharm Med, 2019, 33(5): 373-377.
|
[9] |
世界卫生组织. 国际功能、 残疾和健康分类(国际中文增补版)[M]. 邱卓英,译. 日内瓦: 世界卫生组织, 2015.
|
|
World Health Organization.International Classification of Functioning, Disability and Health-International Chinese Supplement)[M]. QIU Z Y, trans trans. Geneva: World Health Organization, 2015.
|
[10] |
邱卓英, 李伦, 陈迪, 等. 基于世界卫生组织国际健康分类家族康复指南研究:理论架构和方法体系[J]. 中国康复理论与实践, 2020, 26(2): 125-135.
|
|
QIU Z Y, LI L, CHEN D, et al. Research on rehabilitation guidelines using World Health Organization Family International Classifications: framework and approaches[J]. Chin J Rehabil Theory Pract, 2020, 26(2): 125-135.
|
[11] |
World Health Organization. ICD-11[S/OL]. (2024-01-01) [2024-12-03]. https://icd.who.int/browse/2024-01/mms/en.
|
[12] |
National Library of Medicine. SNOMED CT International Edition[EB/OL]. (2025-01-01) [2025-01-06]. https://www.nlm.nih.gov/healthit/snomedct/international.html.
|
[13] |
杨亚茹, 邱卓英, 陈迪. 康复病历的内容结构与数据标准研究[J]. 中国康复理论与实践, 2025, 31(1): 21-32.
doi: 10.3969/j.issn.1006-9771.2025.01.002
|
|
YANG Y R, QIU Z Y, CHEN D, et al. Structure, content and data standardization of rehabilitation medical records[J]. Chin J Rehabil Theory Pract, 2025, 31(1): 21-32.
|
[14] |
XIONG Y, YAN L, LI X, et al. Pattern classification in traditional Chinese medicine and precision medicine: a narrative review[J]. Longhua Chinese Medicine, 2021, 4(2): 1-13.
|
[15] |
MATOS L C, MACHADO J P, MONTEIRO F J, et al. Understanding traditional Chinese medicine therapeutics: an overview of the basics and clinical applications[J]. Healthcare (Basel), 2021, 9(3): 257.
|
[16] |
LI L, YAO H, WANG J, et al. The role of Chinese Medicine in health maintenance and disease prevention: application of constitution theory[J]. Am J Chin Med, 2019, 47(3): 495-506.
|
[17] |
常岑, 张润润, 时一鸣, 等. 中医疗法治疗类风湿性关节炎的研究进展[J]. 中国中药杂志, 2023, 48(2): 329-335.
|
|
CHANG C, ZHANG R R, SHI Y M, et al. Traditional Chinese medicine therapy for rheumatoid arthritis: a review[J]. Chin J Chin Materia Medica, 2023, 48(2): 329-335.
|
[18] |
MEI F, YAO M, WANG Y, et al. Acupuncture for knee osteoarthritis: a systematic review and meta-analysis[J]. J Evid Based Med, 2023, 16(2): 138-140.
|
[19] |
LUO Y, HU B, YUAN Z, et al. Emerging insights into traditional Chinese medicine associated with neurodegenerative diseases: a bibliometric analysis[J]. J Ethnopharm, 2025, 337(2): 118785.
|
[20] |
XIE R, LIU L, WANG R, et al. Traditional Chinese medicine for myasthenia gravis: study protocol for a network meta-analysis[J]. Medicine (Baltimore), 2020, 99(29): e21294.
|
[21] |
国家中医药管理局国家卫生健康委员会. 国家中医药管理局国家卫生健康委员会关于印发«中医病证分类与代码»和«中医临床诊疗术语»的通知[EB/OL]. (2020-11-16) [2025-01-10]. https://www.gov.cn/zhengce/zhengceku/2020-11/24/content_5563703.htm.
|
[22] |
国家市场监督管理总局、国家标准化管理委员会. 中医临床诊疗术语第1部分:疾病[S]. 2023-03-17. GB/T 16751.1-2023.
|
|
State Administration for Market Regulation, National Standardization Administration. Clinic terminology of traditional Chinese medical diagnosis and treatment—Part 1: Diseases [S]. 2023-03-17. GB/T 16751.1-2023.
|
[23] |
国家市场监督管理总局、中国国家标准化管理委员会. 中医临床诊疗术语第2部分:证候[S]. 2021-11-26. GB/T16751.2-2021.
|
|
State Administration for Market Regulation, National Standardization Administration. Clinic terminology of traditional Chinese medical diagnosis and treatment—Part 2: Syndromes/patterns [S]. 2021-11-26. GB/T16751.2-2021.
|
[24] |
国家市场监督管理总局、国家标准化管理委员会. 中医临床诊疗术语第3部分:治法[S]. 2023-03-17. GB/T 16751.3-2023.
|
|
State Administration for Market Regulation, National Standardization Administration. Clinic terminology of traditional Chinese medical diagnosis and treatment—Part 3: Therapeutic methods [S]. 2023-03-17. GB/T 16751.3-2023.
|
[25] |
杨亚茹, 杨剑. 基于ICD-11和ICF的活动和参与与生活质量测量工具的内容比较[J]. 中国康复理论与实践, 2023, 29(12): 1454-1464.
doi: 10.3969/j.issn.1006-9771.2023.12.010
|
|
YANG Y R, YANG J. Content comparison of assessment tools of activity and participation, and quality of life: based on ICD-11 and ICF[J]. Chin J Rehabil Theory Pract, 2023, 29(12): 1454-1464.
|
[26] |
WIŚNIOWSKA-SZURLEJ A, SOZAŃSKA A B, BROŻONOWICZ J, et al. Value of using the ICF core set for patients with musculoskeletal conditions in outpatient rehabilitation facilities in South-Eastern Poland[J]. Ann Agric Environ Med, 2024, 31(4): 579-587.
|
[27] |
BAGRAITH K S, STRONG J. The International Classification of Functioning, Disability and Health (ICF) can be used to describe multidisciplinary clinical assessments of people with chronic musculoskeletal conditions[J]. Clin Rheumatol, 2013, 32(3): 383-389.
doi: 10.1007/s10067-012-2130-1
pmid: 23318704
|
[28] |
JIANG M, ZHANG C, CAO H, et al. The role of Chinese medicine in the treatment of chronic diseases in China[J]. Planta Med, 2011, 77(9): 873-881.
doi: 10.1055/s-0030-1270983
pmid: 21472645
|
[29] |
ZHU P, YE X, ZHAO Q. Successful surgical treatment of descending aorta interruption: a case report[J]. Heart Surg Forum, 2018, 21(3): E175-E176.
|
[30] |
LI T, WANG S, CHENG K, et al. Comparing the efficacy of two different temperature stimulation in warm acupuncture on acute low back pain: a randomized controlled trial[J]. Integr Med Res, 2022, 11(1): 100748.
|
[31] |
LI T, WANG S, ZHANG S, et al. Evaluation of clinical efficacy of silver-needle warm acupuncture in treating adults with acute low back pain due to lumbosacral disc herniation: study protocol for a randomized controlled trial[J]. Trials, 2019, 20(1): 470.
doi: 10.1186/s13063-019-3566-2
pmid: 31366405
|
[32] |
MAA S H, SUN M F, WU C C. The effectiveness of acupuncture on pain and mobility in patients with osteoarthritis of the knee: a pilot study[J]. J Nurs Res, 2008, 16(2): 140-148.
|
[33] |
ZHU B, TANG C, ZHOU X, et al. Effects of traditional Chinese medicine massage therapy on pain, functional activity, muscle activation patterns and proprioception in knee osteoarthritis: a randomised controlled trial protocol[J]. BMJ Open, 2024, 14(12): e081771.
|
[34] |
CAO B, FANG S, WU Z, et al. Efficacy and safety of traditional Chinese manual therapy (Tuina) in patients with non-specific chronic low back pain: a study protocol for a randomised controlled trial[J]. BMJ Open, 2024, 14(3): e081022.
|
[35] |
LEE N W, KIM G H, HEO I, et al. Chuna (or Tuina) manual therapy for musculoskeletal disorders: a systematic review and meta-analysis of randomized controlled trials[J]. Evid Based Complement Alternat Med, 2017, 2017(3): 8218139.
|
[36] |
XIE Y L, HAN F, JIN Y H, et al. Organic integration of traditional Chinese and western medicines-future of clinical practice guidelines of integrated traditional Chinese and western medicines[J]. Chin J Integr Med, 2024, 30(4): 359-365.
|
[37] |
LIU P, CHEN Z, HUANG J, et al. Wutou decoction: a latest review on molecular mechanisms, clinical studies, quality control, pharmacokinetic studies, pharmacological effects, toxicity, and target prediction[J]. J Ethnopharm, 2025, 341(2): 119307.
|